BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

97 related articles for article (PubMed ID: 16636677)

  • 1. SLP65 deficiency results in perpetual V(D)J recombinase activity in pre-B-lymphoblastic leukemia and B-cell lymphoma cells.
    Sprangers M; Feldhahn N; Liedtke S; Jumaa H; Siebert R; Müschen M
    Oncogene; 2006 Aug; 25(37):5180-6. PubMed ID: 16636677
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The BCR-ABL1 kinase bypasses selection for the expression of a pre-B cell receptor in pre-B acute lymphoblastic leukemia cells.
    Klein F; Feldhahn N; Harder L; Wang H; Wartenberg M; Hofmann WK; Wernet P; Siebert R; Müschen M
    J Exp Med; 2004 Mar; 199(5):673-85. PubMed ID: 14993251
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pre-B-cell leukemias in Btk/Slp65-deficient mice arise independently of ongoing V(D)J recombination activity.
    Ta VB; de Haan AB; de Bruijn MJ; Dingjan GM; Hendriks RW
    Leukemia; 2011 Jan; 25(1):48-56. PubMed ID: 21030983
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The SRC family kinase LYN redirects B cell receptor signaling in human SLP65-deficient B cell lymphoma cells.
    Sprangers M; Feldhahn N; Herzog S; Hansmann ML; Reppel M; Hescheler J; Jumaa H; Siebert R; Müschen M
    Oncogene; 2006 Aug; 25(36):5056-62. PubMed ID: 16568084
    [TBL] [Abstract][Full Text] [Related]  

  • 5. V(D)J recombinase mediated inter-chromosomal HPRT alterations at cryptic recombination signal sequences in peripheral human T cells.
    Messier TL; O'Neill JP; Finette BA
    Hum Mutat; 2006 Aug; 27(8):829. PubMed ID: 16835902
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Deficiency of the adaptor SLP-65 in pre-B-cell acute lymphoblastic leukaemia.
    Jumaa H; Bossaller L; Portugal K; Storch B; Lotz M; Flemming A; Schrappe M; Postila V; Riikonen P; Pelkonen J; Niemeyer CM; Reth M
    Nature; 2003 May; 423(6938):452-6. PubMed ID: 12761551
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Analysis of mutagenic V(D)J recombinase mediated mutations at the HPRT locus as an in vivo model for studying rearrangements with leukemogenic potential in children.
    Finette BA
    DNA Repair (Amst); 2006 Sep; 5(9-10):1049-64. PubMed ID: 16807138
    [TBL] [Abstract][Full Text] [Related]  

  • 8. V(D)J and immunoglobulin class switch recombinations: a paradigm to study the regulation of DNA end-joining.
    Soulas-Sprauel P; Rivera-Munoz P; Malivert L; Le Guyader G; Abramowski V; Revy P; de Villartay JP
    Oncogene; 2007 Dec; 26(56):7780-91. PubMed ID: 18066091
    [TBL] [Abstract][Full Text] [Related]  

  • 9. V(D)J targeting mistakes occur at low frequency in acute lymphoblastic leukemia.
    Vanura K; Vrsalovic MM; Le T; Marculescu R; Kusec R; Jäger U; Nadel B
    Genes Chromosomes Cancer; 2009 Aug; 48(8):725-36. PubMed ID: 19455608
    [TBL] [Abstract][Full Text] [Related]  

  • 10. PKC eta directs induction of IRF-4 expression and Ig kappa gene rearrangement in pre-BCR signaling pathway.
    Oda A; Ono T; Yamamoto M; Goitsuka R; Kitamura D
    Int Immunol; 2008 Nov; 20(11):1417-26. PubMed ID: 18780722
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The adaptor protein SLP-65 acts as a tumor suppressor that limits pre-B cell expansion.
    Flemming A; Brummer T; Reth M; Jumaa H
    Nat Immunol; 2003 Jan; 4(1):38-43. PubMed ID: 12436112
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The roles of the RAG1 and RAG2 "non-core" regions in V(D)J recombination and lymphocyte development.
    Jones JM; Simkus C
    Arch Immunol Ther Exp (Warsz); 2009; 57(2):105-16. PubMed ID: 19333736
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphocytic progenitor cell origin and clonal evolution of human B-lineage acute lymphoblastic leukemia.
    Davi F; Gocke C; Smith S; Sklar J
    Blood; 1996 Jul; 88(2):609-21. PubMed ID: 8695809
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Immunoglobulin heavy chain locus events and expression of activation-induced cytidine deaminase in epithelial breast cancer cell lines.
    Babbage G; Ottensmeier CH; Blaydes J; Stevenson FK; Sahota SS
    Cancer Res; 2006 Apr; 66(8):3996-4000. PubMed ID: 16618718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. RAG1/2 re-expression causes receptor revision in a model B cell line.
    Da Sylva TR; Fong IC; Cunningham LA; Wu GE
    Mol Immunol; 2007 Feb; 44(5):889-99. PubMed ID: 16701898
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Highly restricted usage of Ig H chain VH14 family gene segments in Slp65-deficient pre-B cell leukemia in mice.
    Ta VB; de Bruijn MJ; Matheson L; Zoller M; Bach MP; Wardemann H; Jumaa H; Corcoran A; Hendriks RW
    J Immunol; 2012 Nov; 189(10):4842-51. PubMed ID: 23066158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Transcription regulators altered in hematologic malignancy.
    Yunis JJ; Thompson JD
    Nouv Rev Fr Hematol (1978); 1991; 33(2):92-6. PubMed ID: 1766862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recombinase, chromosomal translocations and lymphoid neoplasia: targeting mistakes and repair failures.
    Marculescu R; Vanura K; Montpellier B; Roulland S; Le T; Navarro JM; Jäger U; McBlane F; Nadel B
    DNA Repair (Amst); 2006 Sep; 5(9-10):1246-58. PubMed ID: 16798110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A direct interaction between the RAG2 C terminus and the core histones is required for efficient V(D)J recombination.
    West KL; Singha NC; De Ioannes P; Lacomis L; Erdjument-Bromage H; Tempst P; Cortes P
    Immunity; 2005 Aug; 23(2):203-12. PubMed ID: 16111638
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impaired V(D)J recombination and increased apoptosis among B cell precursors in the bone marrow of c-Abl-deficient mice.
    Lam QL; Lo CK; Zheng BJ; Ko KH; Osmond DG; Wu GE; Rottapel R; Lu L
    Int Immunol; 2007 Mar; 19(3):267-76. PubMed ID: 17229817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.